Genetic Virus Vector Market - Global Outlook and Forecast 2023-2027

Report ID: 613946 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Genetic Virus Vector Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Genetic Virus Vector Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Genetic Virus Vector Overall Market Size
    2.1 Global Genetic Virus Vector Market Size: 2021 VS 2027
    2.2 Global Genetic Virus Vector Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Genetic Virus Vector Players in Global Market
    3.2 Top Global Genetic Virus Vector Companies Ranked by Revenue
    3.3 Global Genetic Virus Vector Revenue by Companies
    3.4 Top 3 and Top 5 Genetic Virus Vector Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Genetic Virus Vector Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Genetic Virus Vector Players in Global Market
        3.6.1 List of Global Tier 1 Genetic Virus Vector Companies
        3.6.2 List of Global Tier 2 and Tier 3 Genetic Virus Vector Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Genetic Virus Vector Market Size Markets, 2021 & 2027
        4.1.2 Retroviral Vectors
        4.1.3 Adenoviral Vectors
        4.1.4 Adeno-Associated Viral Vectors
        4.1.5 Other
    4.2 By Type - Global Genetic Virus Vector Revenue & Forecasts
        4.2.1 By Type - Global Genetic Virus Vector Revenue, 2016-2021
        4.2.2 By Type - Global Genetic Virus Vector Revenue, 2022-2027
        4.2.3 By Type - Global Genetic Virus Vector Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Genetic Virus Vector Market Size, 2021 & 2027
        5.1.2 Gene Therapy
        5.1.3 Vaccinology
    5.2 By Application - Global Genetic Virus Vector Revenue & Forecasts
        5.2.1 By Application - Global Genetic Virus Vector Revenue, 2016-2021
        5.2.2 By Application - Global Genetic Virus Vector Revenue, 2022-2027
        5.2.3 By Application - Global Genetic Virus Vector Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Genetic Virus Vector Market Size, 2021 & 2027
    6.2 By Region - Global Genetic Virus Vector Revenue & Forecasts
        6.2.1 By Region - Global Genetic Virus Vector Revenue, 2016-2021
        6.2.2 By Region - Global Genetic Virus Vector Revenue, 2022-2027
        6.2.3 By Region - Global Genetic Virus Vector Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Genetic Virus Vector Revenue, 2016-2027
        6.3.2 US Genetic Virus Vector Market Size, 2016-2027
        6.3.3 Canada Genetic Virus Vector Market Size, 2016-2027
        6.3.4 Mexico Genetic Virus Vector Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Genetic Virus Vector Revenue, 2016-2027
        6.4.2 Germany Genetic Virus Vector Market Size, 2016-2027
        6.4.3 France Genetic Virus Vector Market Size, 2016-2027
        6.4.4 U.K. Genetic Virus Vector Market Size, 2016-2027
        6.4.5 Italy Genetic Virus Vector Market Size, 2016-2027
        6.4.6 Russia Genetic Virus Vector Market Size, 2016-2027
        6.4.7 Nordic Countries Genetic Virus Vector Market Size, 2016-2027
        6.4.8 Benelux Genetic Virus Vector Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Genetic Virus Vector Revenue, 2016-2027
        6.5.2 China Genetic Virus Vector Market Size, 2016-2027
        6.5.3 Japan Genetic Virus Vector Market Size, 2016-2027
        6.5.4 South Korea Genetic Virus Vector Market Size, 2016-2027
        6.5.5 Southeast Asia Genetic Virus Vector Market Size, 2016-2027
        6.5.6 India Genetic Virus Vector Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Genetic Virus Vector Revenue, 2016-2027
        6.6.2 Brazil Genetic Virus Vector Market Size, 2016-2027
        6.6.3 Argentina Genetic Virus Vector Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Genetic Virus Vector Revenue, 2016-2027
        6.7.2 Turkey Genetic Virus Vector Market Size, 2016-2027
        6.7.3 Israel Genetic Virus Vector Market Size, 2016-2027
        6.7.4 Saudi Arabia Genetic Virus Vector Market Size, 2016-2027
        6.7.5 UAE Genetic Virus Vector Market Size, 2016-2027
7 Players Profiles
    7.1 FUJIFILM Diosynth Biotechnologies U.S.A.
        7.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Corporate Summary
        7.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
        7.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Major Product Offerings
        7.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue in Global (2016-2021)
        7.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Key News
    7.2 Sanofi
        7.2.1 Sanofi Corporate Summary
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Genetic Virus Vector Major Product Offerings
        7.2.4 Sanofi Genetic Virus Vector Revenue in Global (2016-2021)
        7.2.5 Sanofi Key News
    7.3 Lonza
        7.3.1 Lonza Corporate Summary
        7.3.2 Lonza Business Overview
        7.3.3 Lonza Genetic Virus Vector Major Product Offerings
        7.3.4 Lonza Genetic Virus Vector Revenue in Global (2016-2021)
        7.3.5 Lonza Key News
    7.4 Merck KGaA
        7.4.1 Merck KGaA Corporate Summary
        7.4.2 Merck KGaA Business Overview
        7.4.3 Merck KGaA Genetic Virus Vector Major Product Offerings
        7.4.4 Merck KGaA Genetic Virus Vector Revenue in Global (2016-2021)
        7.4.5 Merck KGaA Key News
    7.5 GENERAL ELECTRIC COMPANY
        7.5.1 GENERAL ELECTRIC COMPANY Corporate Summary
        7.5.2 GENERAL ELECTRIC COMPANY Business Overview
        7.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Major Product Offerings
        7.5.4 GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue in Global (2016-2021)
        7.5.5 GENERAL ELECTRIC COMPANY Key News
    7.6 Oxford BioMedica
        7.6.1 Oxford BioMedica Corporate Summary
        7.6.2 Oxford BioMedica Business Overview
        7.6.3 Oxford BioMedica Genetic Virus Vector Major Product Offerings
        7.6.4 Oxford BioMedica Genetic Virus Vector Revenue in Global (2016-2021)
        7.6.5 Oxford BioMedica Key News
    7.7 Spark Therapeutics, Inc.
        7.7.1 Spark Therapeutics, Inc. Corporate Summary
        7.7.2 Spark Therapeutics, Inc. Business Overview
        7.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Major Product Offerings
        7.4.4 Spark Therapeutics, Inc. Genetic Virus Vector Revenue in Global (2016-2021)
        7.7.5 Spark Therapeutics, Inc. Key News
    7.8 uniQure N.V.
        7.8.1 uniQure N.V. Corporate Summary
        7.8.2 uniQure N.V. Business Overview
        7.8.3 uniQure N.V. Genetic Virus Vector Major Product Offerings
        7.8.4 uniQure N.V. Genetic Virus Vector Revenue in Global (2016-2021)
        7.8.5 uniQure N.V. Key News
    7.9 FinVector Vision Therapies
        7.9.1 FinVector Vision Therapies Corporate Summary
        7.9.2 FinVector Vision Therapies Business Overview
        7.9.3 FinVector Vision Therapies Genetic Virus Vector Major Product Offerings
        7.9.4 FinVector Vision Therapies Genetic Virus Vector Revenue in Global (2016-2021)
        7.9.5 FinVector Vision Therapies Key News
    7.10 Brammer Bio
        7.10.1 Brammer Bio Corporate Summary
        7.10.2 Brammer Bio Business Overview
        7.10.3 Brammer Bio Genetic Virus Vector Major Product Offerings
        7.10.4 Brammer Bio Genetic Virus Vector Revenue in Global (2016-2021)
        7.10.5 Brammer Bio Key News
    7.11 Cell and Gene Therapy Catapult
        7.11.1 Cell and Gene Therapy Catapult Corporate Summary
        7.11.2 Cell and Gene Therapy Catapult Business Overview
        7.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Major Product Offerings
        7.11.4 Cell and Gene Therapy Catapult Genetic Virus Vector Revenue in Global (2016-2021)
        7.11.5 Cell and Gene Therapy Catapult Key News
    7.12 Cobra Biologics
        7.12.1 Cobra Biologics Corporate Summary
        7.12.2 Cobra Biologics Business Overview
        7.12.3 Cobra Biologics Genetic Virus Vector Major Product Offerings
        7.12.4 Cobra Biologics Genetic Virus Vector Revenue in Global (2016-2021)
        7.12.5 Cobra Biologics Key News
    7.13 REGENXBIO Inc.
        7.13.1 REGENXBIO Inc. Corporate Summary
        7.13.2 REGENXBIO Inc. Business Overview
        7.13.3 REGENXBIO Inc. Genetic Virus Vector Major Product Offerings
        7.13.4 REGENXBIO Inc. Genetic Virus Vector Revenue in Global (2016-2021)
        7.13.5 REGENXBIO Inc. Key News
    7.14 Kaneka Eurogentec S.A.
        7.14.1 Kaneka Eurogentec S.A. Corporate Summary
        7.14.2 Kaneka Eurogentec S.A. Business Overview
        7.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Major Product Offerings
        7.14.4 Kaneka Eurogentec S.A. Genetic Virus Vector Revenue in Global (2016-2021)
        7.14.5 Kaneka Eurogentec S.A. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Genetic Virus Vector Market Opportunities & Trends in Global Market
    Table 2. Genetic Virus Vector Market Drivers in Global Market
    Table 3. Genetic Virus Vector Market Restraints in Global Market
    Table 4. Key Players of Genetic Virus Vector in Global Market
    Table 5. Top Genetic Virus Vector Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Genetic Virus Vector Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Genetic Virus Vector Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Genetic Virus Vector Product Type
    Table 9. List of Global Tier 1 Genetic Virus Vector Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Genetic Virus Vector Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Genetic Virus Vector Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Genetic Virus Vector Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Genetic Virus Vector Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Genetic Virus Vector Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Genetic Virus Vector Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Genetic Virus Vector Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Genetic Virus Vector Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Genetic Virus Vector Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Genetic Virus Vector Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Genetic Virus Vector Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Genetic Virus Vector Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Genetic Virus Vector Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Genetic Virus Vector Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Genetic Virus Vector Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Genetic Virus Vector Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Genetic Virus Vector Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Genetic Virus Vector Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Genetic Virus Vector Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Genetic Virus Vector Revenue, (US$, Mn), 2022-2027
    Table 30. FUJIFILM Diosynth Biotechnologies U.S.A. Corporate Summary
    Table 31. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product Offerings
    Table 32. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 33. Sanofi Corporate Summary
    Table 34. Sanofi Genetic Virus Vector Product Offerings
    Table 35. Sanofi Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 36. Lonza Corporate Summary
    Table 37. Lonza Genetic Virus Vector Product Offerings
    Table 38. Lonza Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 39. Merck KGaA Corporate Summary
    Table 40. Merck KGaA Genetic Virus Vector Product Offerings
    Table 41. Merck KGaA Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 42. GENERAL ELECTRIC COMPANY Corporate Summary
    Table 43. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product Offerings
    Table 44. GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 45. Oxford BioMedica Corporate Summary
    Table 46. Oxford BioMedica Genetic Virus Vector Product Offerings
    Table 47. Oxford BioMedica Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 48. Spark Therapeutics, Inc. Corporate Summary
    Table 49. Spark Therapeutics, Inc. Genetic Virus Vector Product Offerings
    Table 50. Spark Therapeutics, Inc. Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 51. uniQure N.V. Corporate Summary
    Table 52. uniQure N.V. Genetic Virus Vector Product Offerings
    Table 53. uniQure N.V. Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 54. FinVector Vision Therapies Corporate Summary
    Table 55. FinVector Vision Therapies Genetic Virus Vector Product Offerings
    Table 56. FinVector Vision Therapies Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 57. Brammer Bio Corporate Summary
    Table 58. Brammer Bio Genetic Virus Vector Product Offerings
    Table 59. Brammer Bio Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 60. Cell and Gene Therapy Catapult Corporate Summary
    Table 61. Cell and Gene Therapy Catapult Genetic Virus Vector Product Offerings
    Table 62. Cell and Gene Therapy Catapult Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 63. Cobra Biologics Corporate Summary
    Table 64. Cobra Biologics Genetic Virus Vector Product Offerings
    Table 65. Cobra Biologics Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 66. REGENXBIO Inc. Corporate Summary
    Table 67. REGENXBIO Inc. Genetic Virus Vector Product Offerings
    Table 68. REGENXBIO Inc. Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
    Table 69. Kaneka Eurogentec S.A. Corporate Summary
    Table 70. Kaneka Eurogentec S.A. Genetic Virus Vector Product Offerings
    Table 71. Kaneka Eurogentec S.A. Genetic Virus Vector Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Genetic Virus Vector Segment by Type
    Figure 2. Genetic Virus Vector Segment by Application
    Figure 3. Global Genetic Virus Vector Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Genetic Virus Vector Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Genetic Virus Vector Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Genetic Virus Vector Revenue in 2020
    Figure 8. By Type - Global Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 12. US Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 16. Germany Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 17. France Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 24. China Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 28. India Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 30. Brazil Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Genetic Virus Vector Revenue Market Share, 2016-2027
    Figure 33. Turkey Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Genetic Virus Vector Revenue, (US$, Mn), 2016-2027
    Figure 37. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Sanofi Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Lonza Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Merck KGaA Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Oxford BioMedica Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Spark Therapeutics, Inc. Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. uniQure N.V. Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. FinVector Vision Therapies Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 46. Brammer Bio Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 47. Cell and Gene Therapy Catapult Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 48. Cobra Biologics Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 49. REGENXBIO Inc. Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 50. Kaneka Eurogentec S.A. Genetic Virus Vector Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Genetic Virus Vector Market In Medical Care report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genetic Virus Vector Market In Medical Care report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genetic Virus Vector Market In Medical Care report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports